Provided by Tiger Trade Technology Pte. Ltd.

MasterBrand, Inc.

8.28
-0.2100-2.47%
Post-market: 8.280.00000.00%16:47 EDT
Volume:1.87M
Turnover:15.56M
Market Cap:1.06B
PE:39.43
High:8.45
Open:8.37
Low:8.24
Close:8.49
52wk High:14.22
52wk Low:7.38
Shares:127.54M
Float Shares:106.28M
Volume Ratio:0.72
T/O Rate:1.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2100
EPS(LYR):0.2100
ROE:2.02%
ROA:3.37%
PB:0.79
PE(LYR):39.43

Loading ...

BRIEF-Masterbrand Inc - Co & Its Units Enter Second Amendment To Credit Agreement On March 26, 2026 - SEC Filing

Reuters
·
Mar 27

MasterBrand Inc - Second Amendment Adds New Pricing Category for Loan Margin Over Base Rate - SEC Filing

THOMSON REUTERS
·
Mar 27

MasterBrand Inc - Second Amendment Changes Financial Covenant Thresholds Until Jan 1, 2027 or Merger Effective Date - SEC Filing

THOMSON REUTERS
·
Mar 27

MasterBrand Inc - Co & Its Units Enter Second Amendment to Credit Agreement on March 26, 2026 - SEC Filing

THOMSON REUTERS
·
Mar 27

MasterBrand amends credit agreement with JPMorgan Chase Bank; covenant thresholds narrow until Jan. 1, 2027

Reuters
·
Mar 27

Stock Track | MasterBrand Plunges 16.71% After-Hours on Q4 Earnings Miss and Weak Outlook

Stock Track
·
Feb 11

MasterBrand Q4 net sales fall, plans $30 mln cost savings

Reuters
·
Feb 11

MasterBrand Q4 Adj. EPS $(0.02) Misses $0.14 Estimate, Sales $644.600M Beat $607.600M Estimate

Benzinga
·
Feb 11

BRIEF-MasterBrand Q4 Adjusted EPS USD -0.02

Reuters
·
Feb 11

MasterBrand Inc: for Full Year 2026, Co Expects Addressable Market to Be Down Mid-Single Digits

THOMSON REUTERS
·
Feb 11

MasterBrand Outlook Q1 Adjusted EPS in Range of $-0.06 to $0.00

THOMSON REUTERS
·
Feb 11

MasterBrand Inc: $30 Mln of Cost Rationalization Expected to Be Achieved in 2026

THOMSON REUTERS
·
Feb 11

MasterBrand Inc Outlook Q1 Net Sales YoY Decrease of Mid-Single-Digit to High-Single-Digit Percentage

THOMSON REUTERS
·
Feb 11

Earnings Preview: MasterBrand, Inc.: This quarter’s revenue is expected to decrease by 16.14%, and institutional views are cautious

Earnings Agent
·
Feb 03

MasterBrand Inc. Partners with Cambria to Debut Feature Kitchen at KBIS 2026

Reuters
·
Jan 29

MasterBrand Inc. to Announce Financial Results and Host Conference Call

Reuters
·
Jan 14

Athira Pharma Announces Exclusive License to Lasofoxifene Phase 3 Development Program for Metastatic Breast Cancer Candidate and a Financing for up to $236 Million

GlobeNewswire
·
Dec 18, 2025

BriaCell’s Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout

GlobeNewswire
·
Dec 09, 2025

Immutep to Present New Data from AIPAC-003 Phase II at the 2025 San Antonio Breast Cancer Symposium

GlobeNewswire
·
Dec 02, 2025

Prestige Biopharma and Biosidus Enter Exclusive License Agreement for Tuznue® Commercialization in Latin America

prnewswire
·
Nov 26, 2025